Photo: Mandel Ngan/AFP via Getty Images

Vice President Mike Pence told a news briefing Sunday that hydroxychloroquine will be used in a 3,000-person study at Henry Ford Hospital in Detroit to test the effectiveness of the anti-malarial drug in treating novel coronavirus patients.

Why it matters: President Trump has touted the drug as a potential game-changer, but there's no conclusive proof that it works in COVID-19 cases, per National Institute of Allergy and Infectious Diseases director Anthony Fauci.

  • The trial will be "the first major, definitive study in healthcare workers and first responders of hydroxychloroquine as a preventative medication," noted study organizer William O'Neill, an interventional cardiologist and researcher with Henry Ford Health System, in a statement.

Zoom in: The study will "look at whether the drug prevents front-line workers from contracting the virus," according to the statement.

  • Once health care workers and first responders enrolled in the trial provide a blood sample, they'll "receive vials with unidentified, specific pills to take over the next eight weeks," per Henry Ford Health System.
  • These will consist of a once-a-week dose of hydroxychloroquine, a once-a-day dose or a placebo. Participants won't know which group they're in.
"They will ... be contacted weekly and in person at week 4 and week 8 of the study to see if they are exhibiting any symptoms of COVID-19, including dry cough, fever or breathing issues, as well as any medication side effects. At eight weeks, they will be checked again for symptoms, medication side effects, and have blood drawn. Results will be compared among the three groups to see if the medication had any effect."
— Henry Ford Health System statement

Of note: "The study medication was specially procured for this study [from the Food and Drug Administration] and will not impact the supply of medication for people who already take the medication for other conditions," Henry Ford Health System said.

Our thought bubble, per Axios' Sam Baker: Hydroxychloroquine has shown some promise against the coronavirus in a small French study, but it's not federally approved to treat COVID-19, as no official studies had been conducted to determine whether it's both safe and effective for those sick patients.

Go deeper: Inside the epic White House fight over hydroxychloroquine

Editor's note: This article has been updated with more details on the study.

Go deeper

Updated 51 mins ago - Health

8 states set single-day coronavirus case records last week

Data: Compiled by Axios; Map: Danielle Alberti/Axios

8 states set new highs last week for coronavirus infections recorded in a single day, according to the COVID Tracking Project (CTP) and state health departments. Montana, West Virginia, and Wyoming surpassed records from the previous week.

Why it matters: Cases and hospitalizations are rising in Michigan, a state that initially fought the pandemic with strict mitigation efforts, alongside states that took less action against the spread of the virus this spring.

Updated 2 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Politics: Trump says if Biden's elected, "he'll listen to the scientists"Herd immunity claims by top Trump adviser are "pseudoscience," infectious-disease expert says.
  2. Map: 38 states, D.C. see surge in cases.
  3. Health: Coronavirus hospitalizations are on the rise — Fauci says he's "absolutely not" surprised Trump got coronavirus.
  4. Business: Consumer confidence surveys show Americans are getting nervousHow China's economy bounced back from coronavirus.
  5. Sports: We've entered the era of limited fan attendance.
  6. Education: Why education technology can’t save remote learning.
Dion Rabouin, author of Markets
4 hours ago - Economy & Business

The Fed is starting to question its own policies

Illustration: Aïda Amer/Axios

Several officials at the Fed are beginning to worry about asset bubbles and excessive risk-taking as a result of their extraordinary policy interventions, James Politi writes for the Financial Times, citing interviews with multiple Fed presidents and members of the Board of Governors.

Details: Some are now pushing for "tougher financial regulation" as concerns grow that monetary policy is "encouraging behavior detrimental to economic recovery and creating pressure for additional bailouts."